Equities

ProtoKinetix Inc

PKTX:PKC

ProtoKinetix Inc

Actions
  • Price (USD)0.01
  • Today's Change0.00 / 0.00%
  • Shares traded3.00k
  • 1 Year change-54.55%
  • Beta-0.0375
Data delayed at least 15 minutes, as of Jun 28 2024 14:45 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ProtoKinetix, Incorporated is a research and development stage biotechnology company. The Company is focused on scientific medical research of Anti-Freeze Glycoproteins (AFGPs) or anti-aging glycoproteins. The Company’s anti-aging glycopeptide is for ophthalmology, dermatology, transplant support and biomanufacturing. The commercial applications for AAGPs include various health care solutions. In a clinical setting, AAGP is showing its ability to protect cells from inflammation, repair and replace damaged cells and improve cell survivability over time. The Company has not developed a commercially viable product and has not generated any revenue.

  • Revenue in USD (TTM)0.00
  • Net income in USD-400.47k
  • Incorporated1999
  • Employees0.00
  • Location
    ProtoKinetix Inc109 W. MAIN ST.DALTON 44618United StatesUSA
  • Phone+1 (330) 445-4971
  • Fax+1 (604) 926-6632
  • Websitehttps://www.protokinetix.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Avenue Therapeutics Inc0.00-7.18m3.29m3.00--0.7284-----39.36-39.360.004.810.00----0.00-123.08-186.91-1,045.52-287.70------------0.00-------192.15------
GB Sciences Inc0.00-4.03m3.31m3.00---------0.0105-0.01050.00-0.01190.00----0.00-255.86-49.16---131.40--6.03---995.19---8.63---------2,715.25---60.82--
Bio Path Holdings Inc0.00-13.96m3.31m10.00---------27.39-27.390.00-3.480.00----0.00-216.97-70.80-390.65-76.87---------------------15.94------
Manuka Inc671.00k-1.14m3.36m4.00------5.01-0.0128-0.01280.0066-0.01242.410.941237.28167,750.00-410.43-463.75----88.08---170.04-732.150.0194-----------854.23------
Novelstem International Corp15.00k-4.22m3.37m15.00------224.72-0.09-0.090.0003-0.04780.0065--10.00---172.16---1,011.77-------26,418.53-----8.402.34--0.00---446.84------
Lipella Pharmaceuticals Inc477.45k-4.74m3.42m5.00--1.24--7.17-0.7633-0.76330.07470.36380.1232--6.2595,490.00-122.37---146.33-------993.39------0.00--144.15---77.81------
Biostax Corp0.00-1.57m3.49m-----------0.0188-0.01880.00-0.0580.00-------390.77-81.51---------------6.05--------53.32------
ProtoKinetix, Inc.0.00-400.47k3.53m0.00--8.90-----0.0012-0.00120.000.00110.00-------88.14-696.88-101.62-785.51------------0.00------78.22--10.78--
Applied DNA Sciences Inc5.52m-12.50m3.68m53.00------0.667-17.13-17.137.67-0.05580.389310.384.64104,110.80-87.15-88.57-111.09-121.9133.9844.35-223.89-113.261.54-------26.4327.92-18.73--33.80--
Silo Pharma Inc72.12k-3.53m3.69m3.00--0.5354--51.12-1.18-1.200.0241.870.008----24,040.00-39.26-24.90-43.11-26.3991.9082.79-4,889.57-2,757.85----0.00--0.00--7.07------
Onconetix Inc758.90k-45.68m3.73m12.00------4.92-2.41-2.410.04071.910.0156--4.7063,241.67-93.67---137.89---123.62---6,019.45--0.2752-17.120.2352-------176.78------
Allarity Therapeutics Inc0.00-20.94m3.75m5.00---------599.34-599.340.00-18.880.00----0.00-100.46--------------------------3.02------
Phio Pharmaceuticals Corp0.00-9.38m3.77m8.00--0.5669-----3.71-3.710.001.220.00----0.00-113.26-71.92-145.23-84.15-------253,785.70----0.00------5.70--0.00--
Neximmune Inc0.00-25.86m3.78m6.00--1.38-----24.16-24.160.002.160.00----0.00-130.41-115.07-183.16-165.07------------0.00------48.25---44.65--
Ensysce Biosciences Inc1.75m-11.55m3.84m7.00--0.9902--2.20-3.74-3.740.51090.51150.3886--9.06249,514.30-257.00-17.68-574.02-19.42-----661.34-715.78---6.250.0671---11.61--57.64------
Data as of Jun 28 2024. Currency figures normalised to ProtoKinetix Inc's reporting currency: US Dollar USD

Institutional shareholders

0.02%Per cent of shares held by top holders
HolderShares% Held
United Bank (Virginia)as of 31 Mar 202450.60k0.01%
Williams Jones Wealth Management LLCas of 31 Mar 202420.00k0.01%
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.